Status:
RECRUITING
Cold Agglutinin Disease Real World Evidence Registry
Lead Sponsor:
RECORDATI GROUP
Conditions:
Cold Agglutinin Disease (CAD)
Cold Agglutinin Syndrome (CAS)
Eligibility:
All Genders
18+ years
Brief Summary
This is a multinational, multi-center, observational, prospective, longitudinal disease registry designed to collect data on participants with cold agglutinin disease (CAD) or cold agglutinin syndrome...
Eligibility Criteria
Inclusion
- Patient aged ≥18 years
- Patient able to understand the purpose of the study and who (or whose legally authorized representative) provided signed and dated informed consent and authorization to use protected health information in accordance with national and local subject privacy regulations
- Patient with a diagnosis of CAD or CAS as per Investigator judgment based on the diagnosis criteria listed in study protocol
Exclusion
- Patient with mixed warm and cold autoimmune hemolytic anemia, or warm autoimmune hemolytic anemia
- Patient actively participating in a CAD or CAS interventional clinical trial. After a patient completes participation in said trial, he/she may be eligible for enrollment in this registry.
Key Trial Info
Start Date :
December 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 2 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05791708
Start Date
December 12 2019
End Date
November 2 2028
Last Update
November 20 2025
Active Locations (68)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham Site Number : 1230
Birmingham, Alabama, United States, 35205
2
SLO Oncology and Hematology Site Number : 1235
San Luis Obispo, California, United States, 93401
3
Mission Hope Medical Oncology Site Number : 1241
Santa Maria, California, United States, 93454
4
MedStar Georgetown University Hospital / Lombardi Comprehensive Cancer Center Site Number : 1208
Washington D.C., District of Columbia, United States, 20007